Monday, 3 March 2014

The Journal of Toxicology and Health

The Journal of Toxicology and Health

For Aims & Scope and Author's Instructions Visit:   






Supra-supplementation levels of Dawadawa (Pakia biglobosa) powder has toxicity potential in Sprague-Dawley rats

Asiedu-Gyekye Isaac J.(a)*, Awortwe Charles(b), Antwi Daniel A.K.(c), Nyarko Alexander(a)







Photon Ignitor: ISJN22947439D655803032014

Abstract
Dawadawa (Parkia biglobosa) seed powder is used in Ghana as flavouring agents in local dishes, as nutraceutical in the management of diabetes mellitus and cardiovascular diseases. There are concerns about its safety at supra supplemental levels. Both acute (5000 mg/kg) and subacute (2000 mg kg-1, 500 mg kg-1 and 100 mg kg-1) studies using Sprague–Dawley rats of both sexes (150–200 g). The doses were selected based on the LD50 which was above 5000 mg/kg. Blood samples were obtained via cardiac puncture and used for haematological and clinical chemistry analysis. Gross necropsy and histopathology were performed on the kidney, heart and liver. Haematological studies showed a decrease in WBC levels (p<0.052) and platelet count (p<0.038) while histopathological studies showed narrowing and congestion of the lumen of central vein with RBCs as compared to the controls in 60% of the animals treated with both the high and median doses and 20% of photomicrographs from the high dose showed evidence of periglomerular oedema. These results show that dawadawa seed powder is a relatively safe product to be used domestically and as medicinal however, extremely high doses has the capability of causing hepatic and renal disorders.